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BACKGROUND: When acute aortic syndromes (AASs) are suspected, pretest clinical probability assessment and d-dimer (DD) 
testing are diagnostic options allowing standardized care. Guidelines suggest use of a 12-item/3-category score (aortic dis-
section detection) and a DD cutoff of 500 ng/mL. However, a simplified assessment tool and a more specific DD cutoff could 
be advantageous.
METHODS AND RESULTS: In a prospective derivation cohort (n=1848), 6 items identified by logistic regression (thoracic aortic 
aneurysm, severe pain, sudden pain, pulse deficit, neurologic deficit, hypotension), composed a simplified score (AORTAs) 
assigning 2 points to hypotension and 1 to the other items. AORTAs≤1 and ≥2 defined low and high clinical probability, re-
spectively. Age-adjusted DD was calculated as years/age × 10 ng/mL (minimum 500). The AORTAs score and AORTAs≤1/
age-adjusted DD rule were validated in 2 patient cohorts: a high-prevalence retrospective cohort (n=1035; 22% AASs) and 
a low-prevalence prospective cohort (n=447; 11% AASs) subjected to 30-day follow-up. The AUC of the AORTAs score was 
0.729 versus 0.697 of the aortic dissection detection score (P=0.005). AORTAs score assessment reclassified 16.6% to 25.1% 
of patients, with significant net reclassification improvement of 10.3% to 32.7% for AASs and −8.6 to −17% for alternative 
diagnoses. In both cohorts, AORTAs≥2 had superior sensitivity and slightly lower specificity than aortic dissection detection 
≥2. In the prospective validation cohort, AORTAs≤1/age-adjusted DD had a sensitivity of 100%, a specificity of 48.6%, and an 
efficiency of 43.3%.
CONCLUSIONS: AORTAs is a simplified score with increased sensitivity, improved AAS classification, and minor trade-off in 
specificity, amenable to integration with age-adjusted DD for diagnostic rule-out.
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Acute aortic syndromes (AASs) are deadly con-ditions involving the thoracic aorta and include acute aortic dissection (AAD), intramural hema-
toma, penetrating aortic ulcer, and spontaneous aortic 
rupture. AASs are rare in the general population (5–15 
cases/100  000 individuals/y), present with unspecific 
symptoms, and lead to high morbidity and mortality.1 
Currently, highly accurate aortic biomarkers are not avail-
able, and conclusive diagnostic assessment requires 
contrast medium–enhanced computed tomography 
angiography (CTA). However, CTA uses radiation, may 
cause anaphylaxis and kidney injury, and is resource 
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limited. Therefore, optimal patient selection for urgent 
CTA is challenging. Misdiagnosis may affect 1 in 3 to 7 
AASs, leading to worse outcomes.2,3 In the meantime, 
CTA overtesting and high variability in ordering are major 
issues, with diagnostic yields as low as 2% to 3%.4,5
To assist and standardize diagnostic decisions, pre-
test clinical probability assessment has been recom-
mended, as for pulmonary embolism (PE). Guidelines 
have adopted the aortic dissection detection (ADD) 
score as a tool partitioning their diagnostic algo-
rithms.6,7 The ADD score was initially developed from 
a large international registry of AADs and has obtained 
external validation.8,9 However, this tool has limita-
tions.10 First, categorizing and assignment of points 
with a 12-risk-factor/3-risk-category score may be diffi-
cult/impractical in busy emergency departments (EDs). 
Second, several risk factors are rarely encountered in 
everyday practice, and others have vague definitions. 
Third, hypotension and shock, representing key alerts, 
do not define per se a high pretest probability. Finally, 
presence of ≥2 risk factors in a single category does 
not affect ADD score defined probability.
d-dimer (DD), a plasma fibrin degradation product, 
is widely used as a rule-out biomarker of PE. DD lev-
els almost invariably increase in AASs. Using a cut-
off of 500 ng/mL (DD500), DD has a sensitivity of 95% 
to 98% and low to moderate specificity for AASs.11 
Accordingly, low probability plus a negative DD can 
be used to safely avoid CTA in 15% to 50% of pa-
tients.12 As the specificity of DD diminishes with aging, 
an age-adjusted DD cutoff (DDage-adj) is suggested for 
PE rule-out as an alternative to DD500, providing similar 
sensitivity but higher specificity.13 Use of a single DD 
cutoff optimizing specificity to rule out both PEs and 
AASs may be practical and efficient. However, only few 
studies have evaluated DDage-adj for AASs so far.
12,14,15
Herein, we developed a simplified clinical probabil-
ity assessment tool amenable to dichotomic rule-out 
of AASs in combination with DDage-adj. External vali-
dation was pursued in 2 independent patient cohorts, 
by comparison with current standard (ADD score and 
DD500).
METHODS
The data, analytical methods and study materials will 
be made available to other researchers by contacting 
the corresponding author. For expanded methods, see 
Data S1. The study complies with the Declaration of 
Helsinki, the locally appointed ethics committees have 
approved the research protocol, and informed consent 
has been obtained from the participating subjects (or 
their legally authorized representative).
ADD Risk Score
The standard tool used to assess the pretest prob-
ability of AASs was the ADD score, based on 12 risk 
markers classified in 3 categories (Table S1): high-risk 
conditions (Marfan syndrome, family history of aor-
tic disease, known aortic valve disease, recent aortic 
CLINICAL PERSPECTIVE
What Is New?
• The AORTAs is a simple noncategorical 6-item 
score estimating the pretest clinical probability 
of acute aortic syndromes (AASs).
• The AORTAs score was developed from a pro-
spective multicenter cohort of patients with 
suspected AASs, aiming at integration with an 
age-adjusted d-dimer cutoff, already applied for 
rule-out of pulmonary embolism; preliminary 
validation of the AORTAs score was obtained in 
2 independent emergency department cohorts, 
showing higher sensitivity, better AAS classifi-
cation, and lower specificity compared with the 
aortic dissection detection score.
• For rule-out of AASs, the performance of 
AORTAs score plus age-adjusted d-dimer cutoff 
was similar to aortic dissection detection score 
plus d-dimer<500 ng/mL.
What Are the Clinical Implications?
• The AORTAs score can be applied at the bed-
side and ab initio to all patients with suspected 
AAS, independent of hemodynamic status.
• With AORTAs, hypotension or any combina-
tion of items defines a high clinical probability 
of AAS, thus reducing the risk of initial AAS mis-
classification and inappropriate use of d-dimer.
• Integration of AORTAs with age-adjusted d-di-
mer cutoff is practical and clinically meaningful, 
allowing improved single-cutoff rule-out at max-
imized specificity of both AASs and pulmonary 
embolism; further trial is needed for external 
multicenter validation.
Nonstandard Abbreviations and Acronyms
AAD acute aortic dissection
AAS acute aortic syndrome
ADD aortic dissection detection
AltD alternative diagnosis
CTA computed tomography angiography
DD d-dimer
DD500 d-dimer cutoff of 500  ng/mL
DDage-adj age-adjusted d-dimer cutoff
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manipulation, known thoracic aortic aneurysm), high-
risk pain features (sudden, severe, ripping/tearing), and 
high-risk physical examination features (pulse deficit or 
systolic blood pressure differential, focal neurologic 
deficit, new aortic insufficiency murmur, hypotension/
shock).
Derivation Cohort
The overall study design is shown in Figure  1. The 
derivation cohort was obtained from a previous mul-
ticenter, multinational, prospective diagnostic study.16 
Briefly, consecutive ED outpatients aged >18  years 
were enrolled in the presence of red-flag symptoms 
(chest/abdominal/back pain, syncope, perfusion defi-
cit) lasting ≤14  days and a physician-defined clinical 
suspicion of AAS. Case adjudication was based on 
advanced imaging, surgery, autopsy, or 14-day follow-
up data.
Validation Cohorts
Validation of the simplified score and rule was sought 
in 2 independent study cohorts: a retrospective high-
prevalence cohort and a prospective lower-prevalence 
cohort.
Retrospective Validation Cohort
As a high-prevalence population, we used a retrospec-
tive cohort, detailed elsewhere.17 Briefly, this study 
enrolled outpatients presenting to 2 EDs of urban 
teaching hospitals from 2008 to 2013. Inclusion criteria 
were chest pain, back pain, abdominal pain, syncope, 
or symptoms of perfusion deficit, in conjunction with 
the absence of an obvious alternative diagnosis after 
the first medical evaluation. Clinical suspicion of AAS 
was high enough to have all patients undergo a CTA 
for final diagnosis. ADD score and DD test results were 
available for all patients.
Prospective Validation Cohort
As a cohort representative of Western ED practice at 
lower prevalence of AASs, outpatients with suspected 
AAS were prospectively enrolled in 2 urban teach-
ing hospitals in a new study, from January 2018 to 
November 2019. Inclusion criteria were (1) presence 
of at least 1 red-flag symptom among truncal (chest, 
abdominal, or back pain) pain, syncope, neurologi-
cal deficit, and limb ischemia; (2) symptom(s) lasting 
for ≤14  days; and (3) AASs considered as meaning-
ful differential diagnoses by the attending physician. 
Exclusion criteria were age <18 years, primary trauma, 
and an established diagnosis of AAS.
Patient Management
During the ED visit, a case report form including prob-
ability assessment was filled out by the attending 
physician or resident, before availability of blood test 
results and imaging exams. The recommended stand-
ard of care was represented by the European Society 
of Cardiology 2014 guidelines.7 However, physicians 
were free to derogate from guideline indications, and 
clinical decisions were independent from patient’s par-
ticipation in the study. Advanced imaging exams (CTA, 
transesophageal echocardiography, or magnetic reso-
nance angiography) were performed and interpreted 
Figure 1. Overall study design.
AAS indicates acute aortic syndrome; adv. imag., advanced imaging; and AltD, alternative diagnosis.
Study aim Derivation of new score/rule Validation of new score/rule
Study
cohort
Study design prospective multicenter prospective bicenterretrospective bicenter
  241 (13%) AAS
1607 (87%) AltD
   233 (23%) AAS
   802 (77%) AltD
  49 (11%) AAS
398 (89%) AltD
adv. imag. 100% adv. imag. 55%adv. imag. 47%
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by specialized physicians not involved in the study. 
Discharged patients were instructed to return to the 
ED in case of new, worsening, or recurrent symptoms.
d-dimer
Samples obtained during the visit were sent to the 
local laboratory for urgent processing. DD assays were 
the STA-Liatest D-Di assay (Stago, Asnières sur Seine, 
France) and HemosIL d-Dimer HS (Instrumentation 
Laboratory, Bedford, MA, USA). We planned to ana-
lyze the DD test results on the basis of 2 different cut-
offs: 500  ng/mL fibrinogen equivalent units and an 
age-adjusted cutoff (DDadj). DDadj, already applicable 
for the rule-out of PE, was calculated as follows: age 
(years) × 10 ng/mL (with a minimum of 500 ng/mL for 
patients aged ≤50 years; e.g., 500 ng/mL for a patient 
aged 40 years, 600 ng/mL for a patient aged 60 years, 
750 ng/mL for a patient aged 75 years).13,14 The attend-
ing physicians were not blinded to the DD test results.
Case Adjudication
Case adjudication was performed by 2 expert physicians 
who independently assessed ED chart, blood test results 
(excluding DD), imaging data, and 30-day follow-up data. 
The latter included results of a structured telephone inter-
view evaluating subsequent diagnosis of any aortic dis-
ease, ED visits and admissions to hospital, and hospital 
database search for additional ED visits and hospital ad-
missions within 30 days. For ED visits and hospital admis-
sions, medical charts, surgical reports, autopsy reports (if 
applicable), imaging, and blood test results were obtained 
and reviewed. For patients lost to follow-up, vital status 
was checked in the local public registries. In case of dis-
cordant adjudication, discussion between the 2 reviewers 
was planned for final decision.
Statistical Analysis
Age was assessed with mean and SD, and tested with 
Student’s t test. The variable “hours from symptom 
onset,” which was not normally distributed, was as-
sessed with median and interquartile range, and tested 
with the Mann–Whitney U test. Categorical variables 
were assessed with proportion and 95% CI, and tested 
using the χ 2 or Fisher’s exact test.
Multivariate logistic regression analysis was used 
to identify independent predictors among ADD score 
items plus DD, and the natural logarithm of their odds 
ratios was used to weight each predictor. Contingency 
tables were built, including the number of true-posi-
tive, false-positive, false-negative, and true-negative 
patients. Standard diagnostic performance measures 
were sensitivity, specificity, and positive/negative like-
lihood ratio. The failure rate was calculated as false 
negative/(false negative  +  true negative), which cor-
responds to (1 – negative predictive value), as previ-
ously.18 This measure indicates the number of AAS 
cases mistakenly ruled out with the diagnostic rule-
out protocol. The rule-out efficiency was calculated as 
(true negative + false negative) / (true positive + false 
positive + true negative +  false negative). For contin-
gency tables containing cells with a 0 value, CIs were 
calculated using a bootstrap method.19 Sensitivities 
and specificities were compared using an exact bino-
mial method.20 Likelihood ratios were compared using 
a regression model approach.21
The diagnostic performance of different strate-
gies was assessed using receiver operating charac-
teristic (ROC) curve analysis, McNemar test and net 
reclassification improvement (NRI). In ROC analysis, 
the areas under the curves (AUCs) were compared 
using DeLong’s test for paired AUCs. Improvement 
in risk prediction was assessed with NRI, which was 
split for patients with AASs and alternative diagnoses 
(AltDs).22 A positive NRI value indicates improvement 
in risk prediction. The Pauker and Kassirer decision 
threshold model was applied to calculate 2 theoreti-
cal thresholds: a testing threshold and a test-treatment 
threshold.23
The prospective validation study was powered for 
comparison between the sensitivity of a high-probability 
Table 1. Logistic Regression Analysis for Simplified Score Development
Clinical Item OR (95% CI) P Ln (OR) AORTAs Score Points
Known thoracic aortic aneurysm 3.52 (2.18–5.66) <0.001 1.26 1
Severe pain 2.72 (1.86–3.98) <0.001 1.00 1
Sudden-onset pain 2.98 (2.07–4.29) <0.001 1.09 1
Pulse deficit 3.77 (2.24–6.33) <0.001 1.33 1
Neurologic deficit 2.77 (1.41–5.42) 0.003 1.02 1
Hypotension/shock 5.79 (3.38–9.93) <0.001 1.76 2
Known aortic valve disease 0.89 (0.44–1.79) 0.743 — —
Ripping/tearing pain 1.02 (0.66–1.56) 0.936 — —
d-dimer>500 ng/mL 37.67 (18.23–77.82) <0.001 — —
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definition obtained with the new score and the sensitiv-
ity of the standard high-probability definition (ADD ≥2), 
for diagnosis of AASs. Using a type I error of 0.05 (2 
sided) and a power rate of 80% and assuming a prev-
alence of 10% of AASs, we estimated that at least 430 
patients needed to be included.
P values were considered significant if <0.05. 
Statistical analysis was carried out using SPSS soft-
ware version 25.0 (IBM Corp, Armonk, NY), except 
for ROC curve analysis, bootstrap CI, and diagnostic 
accuracy measure comparison (R version 3.6.0; R 
Foundation for Statistical Computing, Vienna, Austria).
RESULTS
Development of a New Simplified Risk 
Score and Dichotomic Rule
The derivation cohort included 1848 ED patients with 
suspected AAS (Figure  1). Demographic and clinical 
characteristics are described elsewhere.16 To create 
a parsimonious model, ADD items with a prevalence 
<5% (Marfan syndrome, family history, new diastolic 
murmur, respectively, 0.3%, 1.7%, and 2.7%) were 
removed. In multivariable logistic regression analysis 
(Table  1), 6 items were found as independent pre-
dictors of AAS diagnosis: thoracic aortic aneurysm, 
severe pain, sudden-onset pain, pulse deficit, neuro-
logic deficit, and hypotension/shock. These variables 
were used to develop a simplified noncategorical as-
sessment tool, amenable to integration with DDage-adj. 
Based on the odds of AAS diagnosis weighted on a 
logarithmic scale, we assigned a score of 2 to hypoten-
sion/shock and a score of 1 to the other variables. The 
sum was called the aorta simplified (AORTAs) score. 
AORTAs ≤1 (associated with a disease probability of 
4.6%; 95% CI, 3.6%–6%), defined low pretest clinical 
probability and AORTAs ≥2 defined high probability 
(Figure S1).
Compared with the ADD score, the AORTAs score 
had superior AUC (P<0.001; Figure S2a) and reclassi-
fied 23.7% of patients (Table S2), with significant NRI 
for both AASs (22.4%; P<0.001) and AltDs (−16.2%, 
P<0.001). AORTAs ≥2 was more sensitive and less 
specific than ADD ≥2 (Table 2). In the derivation co-
hort, the AORTAs ≤1/DDage-adj rule reclassified 16.9% 
of patients (Table S3), with a significant NRI for AltDs 
(−5.4%; P<0.001), and was less specific than the ADD 
≤1/DD500 rule (Table 3).
External Validation of the Simplified Score
As summarized in Figure 1, external validation of the 
new score and integrated rule was conducted in 2 in-
dependent cohorts of patients with suspected AAS 
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(applying advanced imaging adjudication for all pa-
tients) and a low-prevalence prospective cohort (ap-
plying clinical follow-up adjudication). The clinical and 
demographic characteristics of the former cohort 
(n=1035) are detailed elsewhere.17 The latter cohort 
(Figure 2) included 447 patients, whose characteristics 
and diagnostic data are summarized in Table S4 and 
Figure S3. Advanced aortic imaging was performed in 
245 (54.8%) patients; 161 (36.3%) patients were hospi-
talized, and 4 (0.9%) were lost at follow-up (clinical de-
tails in Table S5). An AAS was adjudicated in 49 (11.1%) 
patients: type-A AAD (n=31), type-B AAD (n=7), and 
intramural aortic hematoma (n=11). AltDs were muscle-
skeletal pain (n=119), gastrointestinal disease (60), acute 
coronary syndrome (39), non–AAS-related syncope 
(30), uncomplicated aortic aneurysm (30), pneumonia 
(23), pericarditis (21), PE (10), and other diagnoses (62). 
AORTAs ≤1 was associated with a disease prevalence 
of 4.7% (95% CI, 2.8%–7.7%; Figure 3).
In composite ROC analysis of the validation co-
horts, the AORTAs score had superior AUC versus 
the ADD score (P=0.005; Figure 4A, Figure S2B–S2C). 
Compared with the ADD score, the AORTAs score 
reclassified 16.6% (P<0.001) and 25.1% (P<0.001) of 
patients in the high- and low-probability cohort, re-
spectively. In the high-prevalence cohort (Table S6), 
the AORTAs score reclassified 172 patients, including 
55 with AASs (n=50 low to high P, n=5 high to low P; 
NRI, 19.3%; P<0.001) and 117 with AltDs (n=93 low to 
high P, and n=24 high to low P; NRI −8.6%; P<0.001). 
In the low-prevalence cohort (Table S7), the AORTAs 
score reclassified 111 patients, including 18 with AASs 
(n=17 low to high P, n=1 high to low P; NRI 32.7%; 
P<0.001) and 93 with AltDs (n=80 low to high P, and 
n=13 high to low P; NRI −17%; P<0.001). AORTAs ≥2 
was more sensitive and less specific than ADD ≥2 for 
diagnosis of AASs in both validation cohorts (Table 2).
External Validation of the Integrated Rule
In composite ROC analysis of the validation cohorts, 
the AORTAs ≤1/DDage-adj and the ADD ≤1/DD500 rule 
had similar AUCs (P=0.18; Figure 4B). Compared with 
the ADD ≤1/DD500 rule, the AORTAs ≤1/DDage-adj rule 
reclassified 9% (P=0.91) and 17.4% (P=0.53) of patients 
in the high- and low-prevalence cohort, respectively. 
However, the NRI of the AORTAs≤1/DDage-adj rule was 
not significant for both AASs and AltDs and in both 
cohorts (Tables S8–S9).
The diagnostic performance of the AORTAs ≤1/
DDage-adj and the ADD ≤1/DD500 rules was similar in 
both validation cohorts (Table 3). Integration of AORTAs 
≤1 with DD500, instead, was less specific than both the 
AORTAs ≤1/DDage-adj and the ADD ≤1/DD500 rule (Table 
S10). In the prospective validation cohort, there was 1 
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was a 54-year-old woman with a type B intramural 
aortic hematoma presenting with severe and sudden 
anteroposterior thoracic pain radiating to the abdo-
men. The DD level was 493 ng/mL. With the AORTAs 
score, this patient was classified as high probability and 
was ruled in. In the prospective cohort, the failure rate 
was 0% (0%–2%) for the AORTAs ≤1/DDage-adj rule and 
0.5% (0.01%–2.7%) for the ADD ≤1/DD500 rule. Potential 
computed tomography scans avoided per 100 patients 
were 43 (95% CI, 39–48) for AORTAs ≤1/DDage-adj and 
47 (95% CI, 42–52) for ADD ≤1/DD500 (P=0.53).
According to the Pauker-Kassirer decision thresh-
old model,23–26 the AORTAs ≤1/DDage-adj rule could be 
applied if the probability of AAS is 1.1% to 46.3%, while 
the ADD≤1/DD500 rule could be applied if the probabil-
ity is 1% to 32.6% (Figure 5).
DISCUSSION
We describe development and validation of a simplified 
score assessing the clinical probability of AASs and of 
a rule integrating this score with an age-adjusted DD 
cutoff for diagnostic rule-out. In the latest guidelines, 
pretest clinical probability has received a class I/level 
B recommendation, and integrated DD rule-out a IIa/B 
recommendation.7
Proposals to modify ADD score–based classifica-
tion and diagnostic flowchart have clinical, method-
ological, and pragmatic motivations. In clinical terms, 
the ADD score contradicts clinical gestalt when ap-
proaching patients with hemodynamic instability, 
typically caused by cardiac tamponade, myocardial 
ischemia, or aortic rupture. Per ADD score, hypo-
tension/shock in the absence of risk factors in the 
other 2 categories (e.g., pain not severe, sudden, 
or tearing; unknown aortic aneurysm) defines low 
probability (European Society of Cardiology) or inter-
mediate risk (American Heart Association/American 
College of Cardiology) of AAS.6,7 Because of the cat-
egorical structure of the ADD score, such underesti-
mation persists even with perfusion deficit or aortic 
regurgitation in conjunction with hypotension/shock. 
Similar patients, however, are clinically unsuitable for 
Figure 2. Flow diagram of the prospective low-prevalence validation cohort study. 
590 met inclusion criteria
447 included
143 excluded because D-dimer test result
        not available     
385 ADD score ≤1 62 ADD score ≥2
212 D-dimer <500 ng/mL 173 D-dimer ≥500 ng/mL 
1 acute aorc syndrome
208 alternave diagnoses
29 acute aorc syndromes
143 alternave diagnoses
24 D-dimer <500 ng/mL 38 D-dimer ≥500 ng/mL 
24 alternave diagnoses
19 acute aorc syndromes
19 alternave diagnoses
635 paents  assessed for 
        eligibility
45 excluded for already confirmed 
      AAS diagnosis 
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integrated rule-out and require urgent advanced aor-
tic imaging.
The AORTAs score overcomes this contradiction by 
defining hypotension as a major predictor (2 points) lead-
ing per se to high pretest probability. Thus, AORTAs can 
be applied ab initio to all patients with suspected AAS 
independent of hemodynamic status and in keeping with 
clinical reasoning. Second, the AORTAs score attributes 
a high-probability tag to all patients presenting with >1 
item. For instance, patients with severe and sudden pain, 
or patients with neurological deficit and pulse deficit, are 
defined with AORTAs at high probability of AAS, thus 
Figure 3. Prevalence of acute aortic syndromes associated with (A) AORTAs score and (B) ADD score values, in the 
prospective low-prevalence validation cohort.
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Figure 4. ROC curves of (A) AORTAs versus ADD score, and (B) AORTAs ≤1/DDage-adj vs ADD≤1/DD500 rule, in the validation 
cohorts.
AUC values are presented in insets. N=1478 (282 with acute aortic syndromes, 1196 with alternative diagnoses). ADD indicates aortic 
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excluding DD rule-out. Accordingly, the main advantage 
of the AORTAs score is represented by increased sensi-
tivity (consistently shown in 3 study cohorts), ideally pro-
viding increased safety and earlier diagnosis of AASs. 
A minor trade-off in specificity slightly increases the 
false-positive rate within patients at high probability un-
dergoing urgent CTA. However, integration with a higher 
DD cutoff (providing per se higher specificity12,15) was not 
associated with a significant change in specificity and 
efficiency for rule-out in the validation cohorts.
Under a methodological point of view, the ADD 
score was developed from the IRAD database, a large 
international case series of AADs with minor represen-
tation of intramural aortic hematomas and penetrating 
aortic ulcers.8,24 Formal derivation methods of the ADD 
score are unknown, and several issues regarding its 
development, refinement, validation, implementation, 
and dissemination remain open.10 Most importantly, 
the IRAD database does not allow any estimate of the 
diagnostic accuracy of the ADD score as a screening 
or diagnostic tool, and so far, external validation has 
been attempted in few retrospective and only 1 pro-
spective study.9 In methodological terms, the AORTAs 
score is developed instead through a bottom-up 
approach, taking advantage of a diagnostic prospec-
tive multicenter trial.16 Preliminary external validation is 
provided herein in a large retrospective cohort and in a 
novel prospective cohort of ED outpatients. The deci-
sion threshold analysis also indicates that the AORTAs-
based rule-out strategy could be applied to a wider 
range of disease probabilities.
Pragmatic considerations indicate that the AORTAs 
score may provide additional advantages. First, the 
AORTAs score uses only half of the items of the ADD 
score, which may ease applicability to busy EDs. 
Similar simplification processes have been done for 
commonly used scores such as the simplified Wells 
and Geneva scores for PE.13 Second, application of 
a single higher-specificity cutoff for both AAS and PE 
rule-out appears convenient and practical.
This study has limitations. First, validation was per-
formed in 2 patient cohorts, which were indeed fully 
independent but recruited in the same participating 
centers, potentially limiting external validity. Second, 
the retrospective nature of the first validation cohort 
has limits in score assignment through chart review 
because of potential underreporting of risk markers. 
Third, in the derivation and prospective validation 
Figure 5. Test-treatment threshold analysis based on the prospective validation cohort study data.
(A) Based on Taylor and Iyer25; (B) based on Cochran26; (C) the sensitivity of AORTAs ≤1/DDage-adj was computed as 99%; (D) estimated 
form mortality of treated and untreated acute aortic dissection.25 ADD indicates aortic dissection detection; DDage-adj, age-adjusted 
d-dimer cutoff; Tt, testing threshold; and Tt|x, test-treatment threshold.
Tt = [(Ppos/nd) × (Rrx) + Rt] ÷ [(Ppos/nd ×Rrx) + (Ppos/d × Brx)]
Tt|x= [(Pneg/nd) × (Rrx)–Rt] ÷ [(Pneg/nd ×Rrx) + (Pneg/d × Brx)]
Ppos/nd = probability of a posive result in paents without disease = 1 – specificity
Pneg/nd = probability of a negave result in paents without disease = specificity
Rrx = risk of treatment in paents without disease = 0.010
a  
Rt = risk of diagnosc test = 0.0003
b 
Ppos/d = probability of a posive result in paents with disease = sensivity
c
Pneg/d = probability of a negave result in paents with disease = 1 – sensivity
c
Brx = benefit of treatment in paents with disease = 0.50
d
Tt = 1% Tt|x= 32.6% 100%
B ADD score ≤1 and D-dimer <500 ng/mL
connue tesng initate therapy
Tt = 1.1% Tt|x= 46.3% 100%
A AORTAs score ≤1 and D-dimer <D-dimerage-adj ng/mL
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cohorts, case adjudication was based on follow-up, 
which might lead to potential slight underestimation of 
patients affected by AAS (differential verification bias). 
Finally, the study was powered to evaluate the diag-
nostic accuracy of the AORTAs score, and not for sta-
tistical comparison of different scores/DD integrations. 
A larger multicenter trial is needed for this purpose.
As with other similar tools, the AORTAs score is 
meant to aid in diagnostic decisions and to standard-
ize clinical practice but not to substitute for clinical rea-
soning. Since study results were obtained in patients 
with a clinical suspicion of AAS (leading to a relatively 
high prevalence of AASs), results may not be general-
ized to unselected patients presenting to the ED (e.g., 
with chest pain). Therefore, clinical gestalt should be 
applied by treating physicians for proper selection of 
patients suitable for standardized probability assess-
ment and rule-in/out protocols. Even posttest, a case-
by-case diagnostic decision is always warranted.
In conclusion, we provide bottom-up development 
of a simplified 6-item noncategorical score for stan-
dardized assessment of the pretest probability of AASs, 
amenable to integration with an age-adjusted DD assay 
for rule-out applications (Figure 6). This score is easily 
applicable in the framework of current guidelines and 
clinical practice. In 3 independent cohorts, this score 
consistently showed higher sensitivity, better AAS 
classification and lower specificity compared with the 
ADD score, representing the current standard. Results 
also indicate comparable rule-out performance when 
integrated with DDage-adj. Further external validation is 
needed to evaluate clinical applicability.
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Disease types defining an AAS were non-traumatic AAD, IMH, PAU or SAR, either type A or B based 
on Stanford classification. Case adjudication was dichotomic: AAS present or absent. In patients without AAS, 
an alternative clinical diagnosis was indicated. Pre-specified alternative diagnoses were: acute coronary 
syndrome, gastrointestinal disease, pleuritis or pneumonia, pericarditis, pulmonary embolism, stroke not 
related to AAS, limb ischemia not related to AAS, syncope not related to AAS, uncomplicated aortic aneurysm, 
muscle-skeletal pain and other diagnoses. 
A case was pre-defined by evidence of AAS in advanced imaging, surgery or autopsy data, obtained 
within 30 days from the index visit. For deaths occurring in patients without autopsy data and not subjected 
to advanced imaging or surgery, an AAS was adjudicated as possible if a reasonable alternative diagnosis was 
not found. For patients lacking advanced imaging/surgery data, an AAS was excluded if they had an 
uncomplicated clinical course, or if an AltD was made after a subsequent ED visit or hospital admission during 
the follow-up period. 
Statistical analysis 
General characteristics were assessed with median and interquartile range for continuous variables, 
with proportion and 95% confidence interval (CI) for categorical variables. Statistical differences were 
compared using the Mann-Whitney U test for continuous variables and using the χ2 or the Fisher’s exact test 
for proportions.  
Multivariate logistic regression analysis was used to identify independent predictors among ADD 
score items plus D-dimer, and their odds ratios were used to weight each predictor for the new score. 
Contingency tables were used to calculate diagnostic performance measures: sensitivity, specificity, positive, 
positive/negative likelihood ratio (LR+/-). The failure rate was calculated as FN/(FN+TN), i.e. number of 
patients with AASs satisfying rule-out criteria divided by the total number of patients satisfying rule-out 
criteria. The rule-out efficiency was calculated as (TN+FN)/(TP+FP+TN+FN), i.e. number of patients ruled-out 
by each integrated strategy divided by total number of patients tested. For contingency tables containing 
cells with a 0 value, CIs were calculated using a bootstrap method.19 Sensitivities and specificities were 
compared using an exact binomial method, which tests the null hypothesis that the difference between the 
two scores is equal to zero.20 LRs were confronted according to a regression model approach which tests the 
null hypothesis that the ratio of the LRs between the two scores is equal to one.21  
The diagnostic performance of different strategies was assessed using ROC curve analysis, McNemar 
test and net reclassification improvement (NRI). In ROC analysis, the AUCs were compared using DeLong’s 
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diagnostic strategies. In order to assess patient reclassification with the new diagnostic tool and rule, 
improvement in risk prediction was assessed with NRI, which was split for patients with AASs and AltDs. A 
positive NRI value indicates improvement in risk prediction: for AASs, this is represented by reclassification 
from low to high probability; for AltDs, this is represented by reclassification from high to low probability. A 
negative NRI value indicates worsening in risk prediction: for AASs, this is represented by reclassification from 
high to low probability; for AltDs, this is represented by reclassification from low to high probability. 
The Pauker and Kassirer decision threshold model was applied to calculate two theoretical 
thresholds: a testing threshold (i.e. the probability of AAS at which there is no difference between performing 
the test and withholding the treatment) and a test-treatment threshold (i.e. the probability of AAS at which 
there is no difference between performing the test and administering the treatment).23  
The prospective validation study was powered to allow comparison between the sensitivity (sens1) 
of a high-probability definition obtained with the new diagnostic tool and the sensitivity (sens0) of the 
standard high-probability definition (ADD score ≥2), for diagnosis of AASs. Sensitivity was chosen as the 
primary outcome, to focus on the safety and rule-out potential of the new score. The values of sens1 and 
sens0 were obtained from the prospective derivation cohort data. Using a type I error of 0.025 (1 sided), a 
type II error of 0.2 and assuming a prevalence of 10% of AASs, we estimated that at least 430 patients needed 
to be included.  
P-values were considered significant if <0.05. Statistical analysis was carried out using the SPSS 
software version 25.0 (IBM Corp.), except for ROC curve analysis, bootstrap CI and diagnostic accuracy 
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Table S1. Aortic dissection detection (ADD) score items. For each risk category, one point is assigned if one or more risk factors is present. The ADD sore can 
therefore vary from 0 to 3. 
High-risk conditions High-risk pain features High-risk exam features 
• Marfan syndrome or other connective tissue disease
• Family history of aortic disease
• Known aortic valve disease
• Recent aortic manipulation
• Known thoracic aortic aneurysm
Chest, back, or abdominal pain described as: 
• Abrupt in onset
• Severe in intensity
• Ripping or tearing in quality
• Pulse deficit or systolic blood pressure
differential
• Focal neurologic deficit (with pain)
• Murmur of aortic insufficiency (new, with
pain)




 http://ahajournals.org by on M
arch 10, 2021
Table S2. Cross-tabulation of low/high probability classification based on ADD and AORTAs score in the 
derivation cohort. The AORTAs score reclassified 438 (23.7%) patients (P<0.001), including 72 with AASs 
(n=63 low to high-P, n=9 high to low-P; NRI 22.4%, P<0.001) and 366 with AltDs (n=313 low to high-P, and 
n=53 high to low-P; NRI -16.2%, P<0.001).  










1131 376 1507 (81.5%) 
108 (44.8%) AASs 







62 279 341 (18.5%) 
133 (55.2%) AASs 







54 (22.4%) AASs 
1139 (70.9%) AltDs 
655 (35.4%) 
187 (77.6%) AASs 







 http://ahajournals.org by on M
arch 10, 2021
Table S3. Cross-tabulation of rule-in/out classification based on ADD≤1/DD500 and AORTAs≤1/DDage-adj rules 
in the derivation cohort. Compared to ADD≤1/DD500, the AORTAs≤1/DDage-adj rule reclassified 312 (16.9%) 
patients (P<0.001), including 3 with AAS (n=2 rule-out to rule-in, n=1 rule-in to rule-out; NRI 0.4%, P=0.56) 
and 309 AltDs (n=198 rule-out to rule-in, n=111 rule-in to rule-out; NRI -5.4%, P<0.001). 










3 (1.2%) AASs 
921 (57.3%) AltDs 
Rule-in 





238 (98.8%) AASs 
686 (42.7%) AltDs 
Total 
836 (45.2%) 1012 (54.8%) 1848 (100%) 
2 (0.8%) AASs 
834 (51.9%) AltDs 
239 (99.2%) AASs 
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N (%) N (%) N (%) 
General characteristics 
gender (F) 152 (33.3%) 136 (34.5%) 16 (32.6%) 0.80 
age (years) 63 (16) 62 (16) 70 (12) 0.005 
Hypertension 228 (51.5%) 194 (49.2%) 34 (69.4%) 0.008 
Diabetes 52 (11.7%) 48 (12.2%) 4 (8.2%) 0.41 
Smoke 114 (25.7%) 97 (24.6%) 17 (34.7%) 0.13 
Drug use 3 (0.7%) 2 (0.5%) 1 (2%) 0.30 
Coronary artery disease 55 (12.4%) 53 (13.5%) 2 (4.1%) 0.06 
Presenting symptoms 
Hours from onset 5 (2-24) 5 (2-24) 2 (1-8) 0.006 
Anterior chest pain 305 (68.8%) 272 (69%) 33 (67.3%) 0.81 
Posterior chest pain 153 (34.5%) 131 (33.2%) 22 (44.9%) 0.11 
Abdominal pain 84 (19%) 74 (18.8%) 10 (20.4%) 0.78 
Lumbar pain 27 (6.1%) 23 (5.8%) 4 (8.2%) 0.52 
Syncope 51 (11.5%) 47 (11.9%) 4 (8.2%) 0.44 
Perfusion deficit 20 (4.5%) 15 (3.8%) 5 (10.2%) 0.06 
ADD score factors 
Marfan syndrome 1 (0.2%) 1 (0.3%) 0 (0%) 1.00 
Family history of AAS 5 (1.1%) 5 (1.3%) 0 (0%) 1.00 
Known aortic valve disease 25 (5.6%) 18 (4.6%) 7 (14.3%) 0.013 
Recent aortic manipulation 4 (0.9%) 3 (0.8%) 1 (2%) 0.38 
Known thoracic aortic aneurysm 45 (10.2%) 34 (8.6%) 11 (22.9%) 0.009 
Severe pain 198 (44.7%) 164 (41.6%) 34 (69.4%) <0.001 
Sudden-onset pain 168 (37.9%) 134 (34%) 34 (69.4%) <0.001 
Ripping/tearing pain 37 (8.4%) 26 (6.6%) 11 (22.4%) 0.001 
Pulse deficit 18 (4.1%) 11 (2.8%) 7 (14.3%) 0.002 
Neurological deficit 14 (3.2%) 9 (2.3%) 5 (10.2%) 0.013 
New aortic murmur 1 (0.2%) 1 (0.3%) 0 (0%) 1.00 
Hypotension/shock 13 (2.9%) 4 (1%) 9 (18.4%) <0.001 
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Table S5. Characteristics of the patients lost at follow-up in the prospective low-prevalence validation cohort. 
Pt 
N 







Blood test results CXR FoCUS Discharge diagnosis Vital 
status* 
1 58 y.o. male, presented with 




1 2 DD 454 ng/mL, TnT 4 
(normal range < 14), 
WBC 8.04x103/L, 
creatinine 0.83 mg/dL 
Normal - Unspecific GI pain Alive 
2 62 y.o. female with 




0 0 DD 275 ng/mL, TnT 11 
ng/L, WBC 6.18 
x103/L, creatinine 
0.81 mg/dL 





3 71 y.o. male with hypertension 
and smoke habit, presented 




1 1 DD 741 ng/mL, TnT 18 
ng/L, WBC 10.22 
x103/L, creatinine 
1.12 mg/dL 
Normal Normal aortic root 
and abdominal aorta 
diameters  
Unspecific GI pain, 
self-discharged 
from the ED 
Alive 
4 73 y.o male with hypertension, 




1 1 DD 36 ng/mL, TnT 11 
ng/L, WBC 6.49 
x103/L, creatinine 
1.02 mg/dL 
- Aortic root 42 mm, 
no direct/indirect 






CXR: chest x-ray; FOCUS: focus cardiac ultrasound; DD: d-dimer; GI: gastro-intestinal; TnT: troponin T; TAA: thoracic aorta aneurysm; WBC: white blood cells 
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Table S6. Cross-tabulation of low/high probability classification based on ADD and AORTAs score in the 










687 143 830 (80.2%) 
152 (65.2%) AASs 







29 176 205 (19.8%) 
81 (34.8%) AASs 







107 (45.9%) AASs 
609 (75.9%) AltDs 
319 (30.8%) 
126 (54.1%) AASs 
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Table S7. Cross-tabulation of low/high probability classification based on ADD and AORTAs score 
in the prospective low-prevalence validation cohort. 










284 97 381 (86%) 
30 (61.2%) AASs 







14 48 62 (14%) 
19 (38.8%) AASs 







14 (28.6%) AASs 
284 (72.1%) AltDs 
145 (32.7%) 
35 (71.4%) AASs 
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Table S8. Cross-tabulation of rule-in/out classification based on ADD≤1/DD500 and AORTAs≤1/DDage-adj 
rules in the retrospective high-prevalence validation cohort. The AORTAs≤1/DDage-adj rule reclassified 93 
patients, including 4 with AASs (n=1 rule-out to rule-in, n=3 rule-in to rule-out; NRI -0.9%, P=0.32) and 89 











2 (0.9%) AASs 
242 (30.2%) AltDs 
Rule-in 





231 (99.1%) AASs 
560 (69.8%) AltD 
Total 
245 (23.7%) 790 (76.3%) 1035 (100%) 
4 (1.7%) AASs 
241 (30%) AltDs 
229 (98.3%) AASs 
561 (70%) AltDs 
233 AASs 
802 AltDs 
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Table S9. Cross-tabulation of rule-in/out classification based on ADD≤1/DD500 and AORTAs≤1/DDage-adj 
rules in the prospective low-prevalence validation cohort. The AORTAs≤1/DDage-adj rule reclassified 77 
patients, including 1 with AAS (rule-out to rule-in; NRI 2%, P=0.32) and 76 with AltDs (n=46 rule-out to rule-
in, n=30 rule-in to rule-out; NRI -4.1%, P=0.07).  










1 (2%) AAS 
208 (52.8%) AltDs 
Rule-in 





48 (98%) AASs 
186 (47.2%) AltDs 
Total 
192 (43.3%) 251 (56.7%) 443 (100%) 
0 AAS 
192 (48.7%) AltDs 
49 (100%) AASs 
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Table S10. Diagnostic performance of the integrated AORTAs≤1/DD500 rule in the study cohorts. 
Study cohorts 
Derivation cohort Validation cohorts 




















(98.0-100%) 1 1 
99.1% 
(98.0-100%) 1 0.5 
100% 
(92.7-100%) 1 1 
Specificity 
47.1% 
(44.7-49.6%) <0.001 <0.001 
25.6% 
(22.5-28.6%) <0.001 <0.001 
43.1% 
(38.3-48.1%) <0.001 <0.001 
LR+ 
1.87 
(1.79-1.97) <0.001 <0.001 
1.33 
(1.28-1.39) <0.001 <0.001 
1.76 
(1.58-1.91) <0.001 <0.001 
LR- 
0.02 
(0.00-0.07) 0.77 0.5 
0.03 
(0.01-0.13) 0.81 0.29 
0 
(0-0.13) <0.001a <0.001a 
AUC 
0.731 
(0.718-0.745) <0.001 <0.001 
0.624 
(0.607-0.640) <0.001 <0.001 
0.716 
(0.691-0.740) 0.005 <0.001 
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 Figure S1. Prevalence of acute aor�c syndromes associated with AORTAs 
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Figure S2. ROC curves of AORTAs and ADD score in the (A) deriva�on cohort, (B) high-prevalence valida�on 
cohort, and (C) low-prevalence valida�on cohort. AUC-ROC values, represented as insets, were compared 
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ED visit
229 underwent advanced imaging
   228 CTA
        1 TEE
217 were not subjected to advanced 
        imaging in the ED
447 study pa�ents
68 alterna�ve diagnoses
49 acute aor�c syndromes
     28 underwent surgery
       5 underwent TEVAR
44 admi�ed to hospital 174 discharged from ED
112 alterna�ve diagnoses
117  admi�ed to hospital 112 discharged from ED 
30-day follow-up
27 underwent advanced imaging
   6 CTA
   2 TEE   
   19 coronary angiography
30-day follow-up
17 underwent advanced imaging
        4 CTA
        3 TEE
        10 coronary angiography
 44  alterna�ve diagnoses 170 alterna�ve diagnoses
1 underwent advanced imaging
        1 CTA
44  completed 30-day FU
     4 lost at follow-up
170  completed 30-day FU
   15 died
102  completed 30-day FU 112  completed 30-day FU
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